Apogee Therapeutics, Inc.
APGE
$39.94
$1.614.20%
12/31/2024 | 09/30/2024 | ||||
---|---|---|---|---|---|
Revenue | -- | -- | |||
Total Other Revenue | -- | -- | |||
Total Revenue | -- | -- | |||
Cost of Revenue | -- | -- | |||
Gross Profit | -- | -- | |||
SG&A Expenses | 20.66% | 18.83% | |||
Depreciation & Amortization | -- | -- | |||
Other Operating Expenses | -- | -- | |||
Total Operating Expenses | 29.30% | 33.01% | |||
Operating Income | -29.30% | -33.01% | |||
Income Before Tax | -37.09% | -44.96% | |||
Income Tax Expenses | -- | -- | |||
Earnings from Continuing Operations | -37.13% | -44.96% | |||
Earnings from Discontinued Operations | -- | -- | |||
Extraordinary Item & Accounting Change | -- | -- | |||
Minority Interest in Earnings | -- | -- | |||
Net Income | -37.13% | -44.96% | |||
EBIT | -29.30% | -33.01% | |||
EBITDA | -29.28% | -33.01% | |||
EPS Basic | -36.03% | -44.23% | |||
Normalized Basic EPS | -36.00% | -44.22% | |||
EPS Diluted | -36.03% | -44.23% | |||
Normalized Diluted EPS | -36.00% | -44.22% | |||
Average Basic Shares Outstanding | 0.80% | 0.50% | |||
Average Diluted Shares Outstanding | 0.80% | 0.50% | |||
Dividend Per Share | -- | -- | |||
Payout Ratio | -- | -- |